LEA随机试验长期结果:膀胱癌根治性膀胱切除术中扩大与标准淋巴结清扫的比较
LEA多中心3期随机试验纳入401例高危T1G3或肌层浸润性膀胱癌(T2-T4a M0)患者,1:1随机接受标准或扩大淋巴结清扫。中位随访58.4个月,扩大清扫未显著改善无复发生存(5年68% vs 60%,HR 0.80,P=0.2)和总生存(5年57% vs 51%,HR 0.84,P=0.2),但癌症特异性生存显著提高(5年76% vs 65%,HR 0.65,P=0.031)。
要点
- 扩大淋巴结清扫未显著改善无复发生存和总生存。
- 扩大清扫组癌症特异性生存显著更高,具有临床意义。
- 至少采用标准模板的细致淋巴结清扫仍是推荐手术方式。
核心结论
- 长期随访下该随机对照试验主要终点无复发生存仍为阴性,但癌症特异性生存为阳性。
研究设计与样本
- 前瞻性多中心3期随机对照试验(LEA AUO AB 25/02;NCT01215071),401例局部可切除高危T1G3或肌层浸润性尿路上皮癌(T2-T4a M0)患者1:1随机接受标准或扩大淋巴结清扫。
主要发现
- 扩大淋巴结清扫对比标准清扫的无复发生存5年率为68% vs 60%(HR 0.80,95%CI 0.56-1.14;P=0.2)。
- 总生存5年率为57% vs 51%(HR 0.84,95%CI 0.64-1.12;P=0.2)。
- 癌症特异性生存5年率为76% vs 65%(HR 0.65,95%CI 0.43-0.96;P=0.031),扩大清扫组显著更高。
临床怎么用
- 对于接受根治性膀胱切除术的膀胱癌患者,至少采用标准模板的细致淋巴结清扫仍是推荐手术方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The extent of lymph node dissection (LND) at the time of radical cystectomy (RC) for bladder cancer (BC) may affect oncologic outcomes. We present updated long-term data from a prospective, multicenter, phase 3 trial involving patients with locally resectable, high-risk T1 grade 3 or muscle-invasive urothelial BC (T2-T4a M0) without neoadjuvant treatment (trial LEA AUO AB 25/02; NCT01215071). A total of 401 patients were randomly assigned 1:1 to either standard LND (sLND: obturator, internal, and external iliac nodes) or extended LND (eLND), which also included the deep obturator, common iliac, presacral, paracaval, interaortocaval, and para-aortic nodes up to the inferior mesenteric artery. Median follow-up for patients alive without disease recurrence was 58.4 mo. The primary endpoint was recurrence-free survival (RFS). Overall survival (OS) and cancer-specific survival (CSS) were secondary endpoints. eLND failed to show superiority over sLND for RFS (5-yr rate: 68% vs 60%; hazard ratio [HR] 0.80, 95% confidence interval [CI] 0.56-1.14; p = 0.2) and OS (5-yr rate: 57% vs 51%; HR 0.84, 95% CI 0.64-1.12; p = 0.2). The CSS rate was significantly higher in the eLND arm (5-yr rate: 76% vs 65%; HR 0.65, 95% CI 0.43-0.96; p = 0.031), which is clinically meaningful. With long-term follow-up, this randomized controlled trial remains negative for the primary endpoint of RFS, but was positive for CSS. Therefore, meticulous LND using at least a standard template remains the recommended surgical approach for patients undergoing RC for BC.
引用
- Heck MM, Lehmann J, Amiel T, et al. Long-term Results from the LEA Randomized Trial: Extended Versus Standard Lymph Node Dissection in Patients with Bladder Cancer Undergoing Radical Cystectomy. Eur Urol. 2025. PMID: 40967930. doi:10.1016/j.eururo.2025.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。